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Abstract: The term congenital hypopigmentary disorders refers to a wide group of heterogeneous 
hereditary diseases, clinically characterized by inborn pigmentary defects of the iris, hair, and/or 
skin. They include Gray Hair Syndromes (GHSs), a rare group of autosomal recessive 
genodermatosis hallmarked by inborn silvery gray hair. GHSs encompass Griscelli, Chediak–
Higashi, Elejalde, and Cross syndromes, which are all characterized by a broad spectrum of severe 
multisystem disorders, including neurological, ocular, skeletal, and immune system impairment. In 
this manuscript, we describe in detail the clinical, trichoscopic, and genetic features of a rare case of 
Griscelli syndrome; moreover, we provide an overview of all the GHSs known to date. Our report 
highlights how an accurate clinical examination with noninvasive methods, like trichoscopy, may 
play a crucial rule in diagnosis of rare and potentially lethal genetic syndromes such as Griscelli 
syndrome, in which timely diagnosis and therapy may modify the clinical course, quality of life, 
and likelihood of survival. 
Keywords: genodermatoses; genetic skin disorders; pigmentation disorders; gray hair syndromes; 
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1. Introduction 
Congenital Pigmentary Disorders (CHD) are a group of heterogeneous, multiorgan diseases, 
clinically featured by inborn pigmentary defects of the iris, hair, and/or skin and a wide range of 
neurological, ocular, skeletal, and hematological disorders [1]. These pigmentary defects are 
congenital and clinically identifiable since the first week of life; therefore, an accurate medical 
evaluation could provide a rapid, noninvasive, and time-saving diagnostic tool [1,2]. 
Based on the dermatological characteristics, congenital pigmentary disorders have been 
classified in gray hair syndromes (GHSs), localized hypopigmentary hair and skin defect syndromes 
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(Waardenburg syndrome and Piebaldism) and generalized hypopigmentary hair and skin defect 
syndromes (Oculocutaneous Albinism and Tietz syndrome) [1–9]. 
Specifically, the term GHS encloses a rare group of autosomal recessive disorders including 
Griscelli syndrome (GS), Chediak–Higashi syndrome (CHS), Elejalde syndrome (ES), and 
Oculocerebral hypopigmentation syndrome, Cross type (OHS). Although GHSs are extremely 
heterogeneous diseases, they are all clinically hallmarked by inborn silvery gray hairs [5]. Table 1 
summarizes the clinical and genetic characteristics of all known GHSs to date [1–10]. 
Here we report an uncommon case of GHS in a child who came to our attention for a congenital 
diffuse hypopigmentation of scalp and body hair. The diagnosis by light microscopy of hair shaft 
together with the presence of typical dermatological and extracutaneous clinical findings led us to 
perform the conclusive genetic analysis. 
2. Case Presentation 
A Caucasian male child came to our attention for inborn generalized hypopigmentation of scalp 
and body hair. He showed congenital silvery gray hair, eyelashes, and eyebrows (Figure 1A), without 
neurological and hearing impairment, facial dimorphism, or history of seizures. 
He was the first child of apparently healthy parents with second-degree consanguinity. His 30-
year-old mother had normally structured blond scalp and body hair. The 37-year-old father 
presented with the complete absence of hair on the scalp and the body. Up to his 20th year, he had 
very light blond hair normally distributed on the scalp and body; subsequently, he developed a 
severe form of alopecia areata that led to alopecia universalis. Both parents were brown-eyed and 
had fair skin, which can darken after sun exposure. 
Our patient’s history was remarkable also for a diagnosis of hemophagocytic 
lymphohistiocytosis (HLH), manifested at 3 months of age as an acute severe multiorgan disease with 
fever, hepatosplenomegaly, pancytopenia, and lymphadenopathy. Chemotherapy and 
hematopoietic cell transplantation from match unrelated donor were performed with immunological 
reconstitution. At 2 years of age, the patient was in good condition and assumed oral cyclosporine 
and corticosteroids. Due to systemic medications, he developed a generalized acquired 
hypertrichosis involving the entire body hairs, which were silvery, likewise scalp hair, eyelashes, and 
eyebrows (Figure 1B). Hair light microscopy showed giant uneven melanin granules mostly located 
approximately in the medullar zone. They were larger than those present in normal hair (Figure 2). 
 
Figure 1. Clinical findings of our patient. (A) A 2-year-old Caucasian child with congenital silvery 
gray scalp hair, eyebrows, and eyelashes and fair skin. He had also brown irises and very fair skin 
with mild tanning capacities after sun exposure; (B) Diffuse silvery hypertrichosis: unmedullated, 
short, and soft hypopigmented hairs on the back of the patient. 
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Due to the finding of HLH, the congenital hair and skin defects, and the consanguinity of the 
parents, a diagnosis of type 2 GS has been suspected. 
 
Figure 2. Light microscopic examination of hair shafts of the proband (A,B) and of a healthy control 
(C,D). Giant uneven melanin granules in the medullar zone of the hair’s proband at light microscopy 
(A) 40× magnification; (B) 100× magnification. Aspect on light microscopy of a black hair of a healthy 
Caucasian control. The pigment is homogeneous and evenly distributed in the hair shaft. (C) 40× 
magnification; (D) 100× magnification. 
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Table 1. Clinical and genetic findings of Gray Hair Syndromes. 
Name of Syndrome 
Clinical Findings 
Genetic 
Findings 
Number of Cases Reported 
Until Now/Epidemiology 
[11] 
Dermatological Signs Nondermatological Signs 
GS 
Griscelli syndrome  
GS, type 1 (GS1) 
GS, type 2 (GS2) 
GS, type 3 (GS3) 
GS Hair: 
Silvery scalp hair, eyebrows, and 
eyelashes 
GS Skin: 
Generalized hypopigmentation 
with tanning capacities after sun 
exposure 
GS1 
Neurologic defects 
epilepsy, endocranic hypertension, cerebellar signs, hemiparesis, spasticity, 
hypotonia, peripheral facial palsy, psychomotor retardation 
Eyes 
Blue to brown iris 
GS1 
MYO5A 
(15q21.2) 
GS1 
20 cases 
GS2 
Immunological defects 
absence of delayed-type cutaneous hypersensitivity, impaired NK cell function, 
hypogammaglobulinemia, hemofagocitic lymphohystiocitosis, accelerated 
phases of hematological disease 
Neurological defects 
progressive neurological deterioration due to cerebral macrophage infiltration 
Eyes 
Blue to brown iris 
GS2 
RAB27A  
(15q21.3) 
GS2  
102 cases 
GS3 
no other systemic signs 
GS3 
MLPH 
(2q37.3) 
GS3 
13 cases 
CHS 
Chediak–Higashi 
syndrome 
CHS Hair: 
Silvery scalp hair, eyebrows, and 
eyelashes 
CHS Skin: 
Fair skin with tanning capacities 
(possible hyperpigmentation after 
sun exposure) 
CHS 
Ocular signs 
possible strabismus, nystagmus, photophobia 
Immunological dysfunction recurrent infections (impaired chemotaxis of 
granulocytes, diminished antibody-dependent cytotoxicity, defective NK cell 
function); uncontrolled macrophage activation and lymphohistiocytic infiltrates 
into major organs (about 85% develop HLH) 
Neurological defects 
progressive neurological deterioration (cerebral macrophage infiltration) 
Eyes 
Blue to brown iris 
CHS 
AR 
LYST 
(1q42-43) 
600 cases 
ES 
Elejalde syndrome 
(neuroectodermal 
melanolysosomal disease) 
ES Hair: 
Leaden-to-silvery scalp hair, 
eyebrows, and eyelashes 
ES Skin: 
Generalized hypopigmentation 
with intense tanning (bronze skin 
color) after sun exposure 
ES 
Neurologic defects 
Like GS1 
Ocular signs 
nystagmus, diplopia, congenital amaurosis 
Other findings 
omphalocele 
ES 
AR 
MYO5A 
(15q21.2) 
20 cases 
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OHS 
Oculocerebral 
hypopigmentation 
syndrome, Cross type 
OHS Hair: 
Silvery scalp hair, eyebrows, and 
eyelashes 
OHS Skin: 
Generalized hypopigmentation 
(very light) with photosensitivity 
OHS 
Neurological signs 
growth deficiency, intellectual disability, spastic tetraplegia, athetoid 
movements, hyperreflexia 
Ocular signs 
microphthalmia, corneal and lens opacity, ectropium, nystagmus, optic nerve 
atrophy, visual impairment/blindness 
Other findings 
Abnormal palate morphology, gingival fibromatosis, dolichocephaly, 
oligophrenia 
OHS 
AR 
gene 
unknown 
(3q27.1q29) 
14 cases 
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After informed consent, we performed genetic analyses on proband’s genomic DNA isolated 
from bone marrow cells and detected a homozygous mutation in the +1G residue of intron 5 (c.467 + 
1G > C) of RAB27A gene, confirming our clinical suspicion (Figure 3). The same mutation in a 
heterozygous state was confirmed in both parents. This mutation affects the invariant splice donor 
site and is predicted to result in exon skipping or the use of an alternative splice site [11]. Therefore, 
in accordance with the standards and guidelines of the American College of Medical Genetics 
(ACMG), we have attributed to this variant a very strong evidence of pathogenicity [12]. 
 
Figure 3. Electropherograms of a control and the affected subject showing the homozygous variant 
c.467 + 1G > C. Genomic DNA was extracted from bone marrow cells of the proband using an 
automated nucleic acid purification platform (Maxwell® 16, Promega). The five coding exons of 
RAB27A gene and their flanking intronic regions were amplified by PCR with specific primers 
(available upon request) and then sequenced by Sanger Sequencing (ABI 3130 Genetic Analyser, 
Applied Biosistems). The cDNA analysis from total RNA isolated from pretransplantation bone 
marrow of the proband or from the parents’ peripheral blood sample could define the effect of 
germline mutations of RAB27A gene on its transcription. 
3. Discussion 
Follicular pigmentation depends on melanogenesis, the biochemical process of melanin 
production, which is regulated genetically at various levels [1,13]. This complex process of synthesis 
of melanin leads to the wide spectrum of human hair colors; in healthy newborns, it can range from 
extremely light blond to red or black, while silvery and white hairs represent clinical signs that always 
require a medical investigation [1,13]. 
Specifically, silvery hair is a characteristic finding of all GHSs; these are infrequent, autosomal-
recessive entities that may also be characterized by immunologic and/or neurologic life-threatening 
alterations. They encompass Griscelli, Chediak–Higashi, Elejalde and Oculocerebral 
hypopigmentation (Cross type) syndromes [1–10]. 
GS consists of a group of multisystem hereditary disorders featured by CHD, immunological 
and/or neurological defects [2–4]. It was described for the first time at the end of the 1970s; 
subsequently, three subtypes have been characterized, based on genetic and clinical features. Diffuse 
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congenital skin and hair hypomelanosis with silvery gray hair shaft represent the clinical 
pathognomonic findings of all subtypes of GS (Table 1) [3–6]. GS, type 1 (GS1) is caused by mutations 
in the gene encoding Myosin-VA (MYO5A); it is featured by primary neurologic impairment, without 
immunologic defects. GS, type 2 (GS2), caused by germline mutations in the RAB27A gene, is 
associated with immune dysfunction without primary neurological impairment. RAB27A gene 
encodes a membrane-bound GTPase, RAB27A, involved in protein transport, especially in 
melanosome transport within melanocytes [3,10]. It is also expressed in T-lymphocytes, in which it 
plays an important role in granule exocytosis of cytotoxic proteins and in the priming at the 
immunologic synapse [10]. The pathogenic defect in the RAB27A gene is responsible both for inborn 
pigmentary impairment and for triggering the HLH, a rapidly progressive, life-threatening 
uncontrolled T-lymphocyte and macrophage activation. GS type 3 (GS3), featured by dermatological 
congenital abnormalities without neurologic and immunologic defects, is due to germline mutations 
in the MLPH (Melanophilin) gene [5]. 
Chediak–Higashi syndrome (CHS) is a rare autosomal recessive immunodeficiency disorder 
characterized by aberrant intracellular protein transport, due to germline mutations in LYST 
lysosomal trafficking regulator gene (also known as CHS1). LYST mutations cause impairment of 
lysosomes function in a wide range of cells, such as immune system cells, melanocytes, neurons, and 
platelets. Therefore, patients with CHS are clinically characterized by recurrent infections, congenital 
pigmentary disorders, a mild hemorrhagic tendency, and progressive neurologic deterioration; about 
85% of them also develop HLH [1,2,7]. 
Elejalde syndrome (ES), also named neuroectodermal melanolysosomal disease, was first 
reported at the end of the 1970s in three South American consanguineous families. To date, 
approximately 20 cases have been reported in the literature, most of which are of Mexican origin. The 
main clinical features of ES patients are silver-leaden hair, a severe central nervous system 
dysfunction, and a wide range of ophthalmologic abnormalities; the skin usually shows a generalized 
hypopigmentation, with ability to tan after sun exposure. The absence of immune dysfunction allows 
differential diagnosis with GS, type 2. Although the exact genetic basis of ES is still unclear, it has 
been hypothesized that ES represents an extremely rare variant of GS type 1 caused by MYO5A gene 
mutations [1,2,8]. 
Oculocerebral hypopigmentation syndrome, Cross type (OHS), is an extremely rare inherited 
disorder featured by generalized hypopigmentation of the skin, silvery scalp and body hair, and a 
wide range of central nervous system and eye abnormalities. OHS was first reported in 1967 and, 
until now, 14 cases have been described, without an ethnic prevalence. Although the gene involved 
in this syndrome is not yet known, recently Chabchoub et al. suggested that OHS maps to 
chromosome 3q27.1q29 [11]. 
4. Conclusions 
Here we provide an overview on GHSs, a group of extremely heterogeneous life-threatening 
congenital diseases, in which timely diagnosis can have a crucial impact on the clinical course, the 
likelihood of survival, and the quality of life. However, due to their rarity and complexity, GHSs can 
represent a diagnostic challenge for clinicians. Furthermore, the high degree of phenotypical overlap 
between these disorders and their subtypes makes the identification of the pathogenic mutations 
mandatory to reach diagnostic certainty. 
This report highlights how an accurate dermatological examination could provide a rapid, 
noninvasive, time-saving diagnostic tool that may help the clinicians to promptly identify which one 
of the congenital pigmentary disorders to investigative first. 
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